skip to main content

Dabigatran Dental Management — ORE Part 1 MCQ

Instant feedback + full explanation. One question, done properly.

ModerateHuman Disease & Dental ManagementDabigatran Dental ManagementORE Part 1

A patient taking dabigatran twice daily, in the morning and evening, requires a dental procedure with a higher risk of post-operative bleeding complications. According to SDCEP, how should their dabigatran be managed on the day of treatment?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Omit the morning dose and take the evening dose at its usual time, no earlier than 4 hours after haemostasis

Explanation lettering: E = shown as A · A = shown as B · B = shown as C · C = shown as D · D = shown as E

The correct answer is A. For a higher-risk bleeding dental procedure, SDCEP advises a patient taking dabigatran twice daily to miss the pre-treatment morning dose. The evening dose is then taken at its usual time, but only if this is at least 4 hours after haemostasis has been achieved; the usual schedule is continued thereafter. Taking both doses normally (B), or taking the morning dose early (D), fails to reduce anticoagulant effect during treatment. A fixed 12-hour delay (C) is not the SDCEP schedule and may create an unnecessary interruption. Omitting both doses until the following morning (E) is an excessive interruption and is not recommended routinely.

Reference: Scottish Dental Clinical Effectiveness Programme. Management of Dental Patients Taking Anticoagulants or Antiplatelet Drugs – Quick Reference Guide, August 2015, section: “NOAC dose schedules for dental procedures with a higher risk of bleeding complications.” https://www.sdcep.org.uk/media/oreflwyz/sdcep-anticoagulants-quick-reference-guide.pdf